Gujarat Terce Laboratories Limited

BSE: 524314
Gujarat Terce Laboratories Limited - pharma in Gandhinagar, Gujarat, India. FY 2026 financials & compliance.
CIN L24100GJ1985PLC007753 Incorporated 28 March 1985 ROC Ahmedabad HQ Gandhinagar, Gujarat, India
Active Listed - BSE: 524314 Public Limited Company pharma MSME · Small
Data last updated
Market Cap
₹33.46 Cr
GUJTERC · BSE
Share Price
₹43.40
+1.05% today
Revenue
₹47.47 Cr
FY 2025-26 · -5.4% YoY
EBITDA
₹3.28 Cr
Margin 6.9%
Net Profit
₹2.44 Cr
FY 2025-26 · +349.0% YoY
ROE
28.5%
ROCE 27.0%
Debt / Equity
0.14
Interest cover 6.3x
Authorised capital
₹11 Cr
Registered with MCA

About Gujarat Terce Laboratories Limited

Data last updated:

Gujarat Terce Laboratories Limited is a public limited company based in Gandhinagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 March 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24100GJ1985PLC007753. Its GSTIN is 24AAACG5528L1ZK (Gujarat). The company holds 9 GST registrations, of which 7 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 524314.

The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹7.79 Cr. It is led by directors including Prajapati Aalap Natubhai (Managing Director) and Prajapati Natwarbhai Parsottam (Whole-Time Director).

Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 122/2 Ravi Estate Bileshwarpura Chhtral, Gandhinagar, Gujarat, India – 382729.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹47.47 Cr, a decline of 5.4% compared to the previous year. For the same year it recorded a net profit of ₹2.44 Cr (net margin 5.1%) and EBITDA of ₹3.28 Cr (EBITDA margin 6.9%). The net worth stands at ₹9.73 Cr (up 50.2% YoY). Total assets are valued at ₹14.87 Cr (up 37.3% YoY).

The company has about 260 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Gujarat Terce Laboratories. As per MCA filings, the company has open charges of ₹9.15 Cr and satisfied charges of ₹8.98 Cr on record. Court records list 36 cases involving the company, including 28 filed by the company and 8 filed against it; 16 cases are pending. The company has 54 deals on record (54 market trades); the latest was in June 2025. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is D.J.Laboratories Private Limited with revenue of ₹50.98 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,010 overdue payments to 90 micro and small suppliers.

Gujarat Terce Laboratories Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0059759). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gujaratterce.in.

Company details

CIN L24100GJ1985PLC007753
Registration Number 007753
Incorporation Date 28 March 1985
ROC Ahmedabad
Listing Status Listed - Listed on BSE (524314)
Company Status Active
Date of Last AGM 21 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0059759

CIN history

Gujarat Terce Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ1985PLC007753, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24100GJ1985PLC007753Current
L24230GJ1985PLC007753Previous
L28112GJ1985PLC007753Previous
Key People
Prajapati Aalap Natubhai Managing Director Prajapati Natwarbhai Parsottam Whole-Time Director Amritbhai Purshottamdas Prajapati Whole-Time Director

Recognitions & Rankings of Gujarat Terce Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0059759

Contact details

Gujarat Terce Laboratories Limited's registered office is in Gandhinagar, Gujarat. Its website is gujaratterce.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    gujaratterce.in
  • Social Media
  • Registered Address
    122/2 Ravi Estate Bileshwarpura Chhtral, Gandhinagar, Gujarat, India – 382729
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gujarat Terce Laboratories Limited, buy the company report.

Comprehensive company report
Gujarat Terce Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Gujarat Terce Laboratories operates one associated brand: Gujarat Terce Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Gujarat Terce Laboratories
Manufacturing and distribution of pharmaceutical products in India.gujaratterce.in

Business activity

The main business activity of Gujarat Terce Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gujarat Terce Laboratories Limited, buy the company report.

Financials of Gujarat Terce Laboratories Limited

FY 2025-26 filings available

Gujarat Terce Laboratories Limited reported revenue of ₹47.47 Cr (down 5.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹47.47 Cr
-5.4% YoY
EBITDA
₹3.28 Cr
-15.7% YoY
Profit After Tax
₹2.44 Cr
+349.0% YoY
Net Worth
₹9.73 Cr
+50.2% YoY
Total Assets
₹14.87 Cr
+37.3% YoY
Total Debt
₹1.30 Cr
+38.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue47.4750.2047.9746.7840.1325.1837.54
Revenue growth-5.4%+4.7%+2.5%+16.6%+59.4%-32.9%-
EBITDA3.283.891.27(2.17)1.12(2.77)0.68
EBITDA margin+6.9%+7.8%+2.7%-4.6%+2.8%-11.0%+1.8%
Profit before tax3.023.400.54(2.90)0.75(2.54)0.44
Net profit2.44(0.98)0.24(1.68)0.88(2.35)0.28
Net profit margin+5.1%-2.0%+0.5%-3.6%+2.2%-9.3%+0.8%
EPS (₹)2.83(1.32)0.33(2.25)1.18(3.40)0.37
Balance sheet
Total assets14.8710.8314.0717.7318.5514.4715.66
Net worth9.736.487.116.868.537.6611.11
Total debt1.300.943.877.276.674.742.60
Cash & bank2.860.780.092.031.511.290.04
Net working capital3.39(0.48)2.025.266.634.645.07
Cash flow
Cash from operations1.713.062.600.03(0.44)(0.16)(1.59)
Cash from investing(0.11)0.46(0.46)0.62(0.87)(0.42)(0.27)
Cash from financing0.47(2.83)(4.08)(0.12)1.531.831.72
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue9.0011.4012.2912.9310.8512.3212.6813.30
Revenue growth (YoY)-17.1%-7.5%-3.1%-2.8%-8.8%---
Other income0.480.080.130.060.090.090.070.08
Total expenses9.5011.1111.1611.0410.8711.2711.5911.64
EBITDA(0.50)0.291.131.89(0.02)1.051.091.66
EBITDA margin-5.6%+2.5%+9.2%+14.6%-0.2%+8.5%+8.6%+12.5%
Depreciation0.110.130.100.100.100.100.100.09
Interest0.030.030.040.070.050.070.080.13
Profit before tax(0.16)0.211.121.78(0.08)0.970.981.52
Tax0.030.100.370.38(0.03)4.36(0.03)0.03

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue9.0011.4012.2912.9310.8512.3212.6813.30
Revenue growth (YoY)-17.1%-7.5%-3.1%-2.8%-8.8%---
Other income0.480.080.130.060.090.090.070.08
Total expenses9.5011.1111.1611.0410.8711.2711.5911.64
EBITDA(0.50)0.291.131.89(0.02)1.051.091.66
EBITDA margin-5.6%+2.5%+9.2%+14.6%-0.2%+8.5%+8.6%+12.5%
Depreciation0.110.130.100.100.100.100.100.09
Interest0.030.030.040.070.050.070.080.13
Profit before tax(0.16)0.211.121.78(0.08)0.970.981.52
Tax0.030.100.370.38(0.03)4.36(0.03)0.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue47.4750.2047.9746.7840.1325.1837.54
Revenue growth-5.4%+4.7%+2.5%+16.6%+59.4%-32.9%-
Other income0.340.310.320.350.310.800.29
Total expenses44.1946.3146.7048.9539.0127.9536.86
Employee cost14.8915.3715.1114.3815.4912.6314.81
EBITDA3.283.891.27(2.17)1.12(2.77)0.68
EBITDA margin+6.9%+7.8%+2.7%-4.6%+2.8%-11.0%+1.8%
Depreciation0.420.380.370.360.280.180.24
Interest0.180.420.680.720.400.390.29
Profit before tax3.023.400.54(2.90)0.75(2.54)0.44
Tax0.834.370.30(1.22)(0.13)(0.01)0.16
Net profit2.44(0.98)0.24(1.68)0.88(2.35)0.28
Net profit margin+5.1%-2.0%+0.5%-3.6%+2.2%-9.3%+0.8%
EPS (₹)2.83(1.32)0.33(2.25)1.18(3.40)0.37
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital7.797.427.427.427.427.427.42
Reserves & surplus1.94(1.29)(0.31)(0.56)1.110.243.69
Shareholders' funds (net worth)9.736.487.116.868.537.6611.11
Secured loans1.210.283.847.246.044.542.57
Unsecured loans0.090.660.030.030.630.200.03
Total debt1.300.943.877.276.674.742.60
Total liabilities14.8710.8314.0717.7318.5514.4715.66
Assets
Gross block8.318.758.408.338.286.166.10
Net block3.253.653.693.984.292.452.30
Capital work in progress0.000.000.000.000.000.000.00
Investments1.350.520.270.270.270.270.27
Inventories3.733.683.934.436.433.743.43
Sundry debtors4.875.075.667.995.475.177.01
Cash & bank balances2.860.780.092.031.511.290.04
Loans & advances1.611.991.541.602.061.831.43
Total current assets13.0711.5211.2216.0515.4712.0311.91
Total current liabilities9.6812.009.2010.798.847.396.84
Net working capital3.39(0.48)2.025.266.634.645.07
Total assets14.8710.8314.0717.7318.5514.4715.66
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.780.092.031.511.290.040.18
Net cash from operating activities1.713.062.600.03(0.44)(0.16)(1.59)
Net cash from investing activities(0.11)0.46(0.46)0.62(0.87)(0.42)(0.27)
Net cash from financing activities0.47(2.83)(4.08)(0.12)1.531.831.72
Net change in cash2.080.69(1.94)0.520.221.24(0.14)
Closing cash2.860.780.092.031.511.290.04
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-5.4%+4.7%+2.5%+16.6%+59.4%-32.9%-
EBITDA growth-15.7%+206.3%+158.5%-293.8%+140.4%-507.4%-
PBT growth-11.2%+529.6%+9998.0%-+9998.0%-+33.3%
Net income growth+349.0%-508.3%+114.3%-290.9%+137.5%-939.3%-
Revenue CAGR (3Y)+0.5%+7.8%+24.0%+7.6%+9.0%-4.6%+14.1%
EBITDA CAGR (3Y)-+51.4%--+33.6%-+104.1%
Profitability & leverage
Net income margin+4.6%-1.9%+0.5%-3.6%+2.2%-10.1%+0.8%
Return on capital employed+27.0%0.0%+7.2%0.0%+6.7%0.0%+5.0%
Return on net worth+28.5%0.0%+3.0%0.0%+10.2%0.0%+2.6%
Debt / equity0.140.350.800.910.700.390.15
Long-term debt / equity0.020.090.170.240.170.030.01
Interest cover6.2911.9775.56-28.4647.62-13.2265.91
Efficiency & per share
Fixed asset turnover5.575.855.735.635.564.114.45
Inventory turnover12.8113.1911.488.627.897.0210.41
Debtors turnover9.559.367.036.957.544.136.51
EPS (₹)2.83(1.32)0.33(2.25)1.18(3.40)0.37
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)12.498.269.589.2511.5010.3314.97

To see the full year-wise statements and ratios of Gujarat Terce Laboratories Limited, buy the company report.

Board of directors of Gujarat Terce Laboratories Limited

Gujarat Terce Laboratories has 6 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Viplav Suryakantbhai KhamarDirector27 Jun 20179 Years 4 MonthsCurrent
Surendrakumar Prakashchandra SharmaDirector10 Aug 20188 Years 2 MonthsCurrent
Prajapati Natwarbhai ParsottamWhole-Time Director28 Mar 198541 Years 7 MonthsCurrent
Prajapati Aalap Natubhai
Also directs: Terce Wellness LLP, Terce Nutriart Private Limited
Managing Director01 Apr 20188 Years 6 MonthsCurrent
Amritbhai Purshottamdas PrajapatiWhole-Time Director01 Mar 200620 Years 7 MonthsCurrent
Avani Vishnubhai Patel
Also directs: Dynemic Products Limited
Director26 May 20251 Years 5 MonthsCurrent
View all directors

Peer comparison

Gujarat Terce Laboratories Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
D.J.Laboratories Private Limited₹50.98 Cr (FY 2025)208.0%Pithampur, Madhya Pradesh, India
Magbro Health Care Private Limited₹50.81 Cr (FY 2025)59.0%Ludhiana, Punjab, India
Ion Healthcare Private Limited₹50.77 Cr (FY 2024)28.0%Zirakpur, Punjab, India
Pioneer Agro Industries Sanvin Laboratories Private Limited₹50.76 Cr (FY 2025)6.0%Mumbai, Maharashtra, India
Ultratech India Limited₹50.24 Cr (FY 2025)84.0%Navi Mumbai, Maharashtra, India
Spica Laboratories Private Limited₹50.21 Cr (FY 2025)-4.0%Hyderabad, Telangana, India
Gujarat Terce Laboratories Limitedthis company₹47.47 Cr (FY 2026)₹2.44 Cr5.1%-5.4%260Gandhinagar, Gujarat, India

To see the full peer comparison of Gujarat Terce Laboratories Limited, buy the company report.

Auditor

Gujarat Terce Laboratories Limited is audited by M. A. Shah & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M. A. Shah & Co.FY 2023112630W

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 40.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 60.00%.

Promoters: 40.00%Retail & Others: 60.00%
Mar 2026
QUARTER
40.00% Promoters
60.00% Retail & Others
Promoter holding - history
Now 40.00% · Mar 2026High 40.00% · Dec 2025Low 37.00% · Jun 2025
36%37.3%38.5%39.8%41%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 37.00%Sep 2025: 37.00%Dec 2025: 40.00%Mar 2026: 40.00%40.00%37.00%40.00%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters40.00%40.00%37.00%37.00%
Public60.00%60.00%63.00%63.00%

Charges & borrowings

Open charges
₹9.15 Cr
Satisfied charges
₹8.98 Cr
Breakdown by lending institutions
Others₹8.79 Cr
Hdfc Bank Limited₹0.36 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Nov 2021100504013Hdfc Bank Limited₹36.12 LakhOpen
08 Jul 200610011413Others₹8.79 CrOpen
30 May 199590107225Bank of Baroda₹2.14 CrSatisfied
05 Jan 199580035100Bank of Baroda₹4.33 CrSatisfied
05 Jan 199590104590Bank of Baroda₹58 LakhSatisfied

To see the full charge records of Gujarat Terce Laboratories Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Gujarat Terce Laboratories Limited has 54 deals on record (54 market trades); the latest was in June 2025.

Total deals
54
Market trades
54

Deals on record (5 of 54)

WhenDealAmountParties
Jan 2017Market trade₹9.1 LakhBuyer: BP Comtrade Private Limited
Seller: BP Comtrade Private Limited
Jan 2017Market trade₹15.3 LakhBuyer: BP Comtrade Private Limited
Seller: an individual
Dec 2012Market trade₹50.7 LakhBuyer: Affluence Shares and Stocks Private Limited , an individual
Seller: Top Detergent Industries Private Limited
Nov 2012Market trade₹12.2 LakhSeller: Top Detergent Industries Private Limited
Aug 2012Market trade₹5.7 LakhSeller: Top Detergent Industries Private Limited

To see the full deal history of Gujarat Terce Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Gujarat Terce Laboratories Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,010 overdue payments to 90 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 90)

SupplierAmount dueDue sinceReported on
Viral Industries Private Limited
Jyoti Packaging
Sureka Pharma
Perennial Medicare
Nenshi Formulation

To see the full MSME payment records of Gujarat Terce Laboratories Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Gujarat Terce Laboratories Limited has a workforce of 260 employees on its EPFO records as of May 20, 2025, across 1 active EPFO establishment.

Employee count
260
Active EPFO establishments
1
Employee growth
-15.86%

GST

Gujarat Terce Laboratories has 9 GST registrations: 7 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
9
Active
7
Cancelled / inactive
2
GSTINStateStatusRegistered on
24AAACG5528L1ZKGujaratActive01 Jul 2017
24AAACG5528L2ZJGujaratActive24 Mar 2025
08AAACG5528L1ZERajasthanActive01 Jul 2017
09AAACG5528L1ZCUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Gujarat Terce Laboratories Limited, buy the company report.

Recent activity

Gujarat Terce Laboratories Limited has 42 board changes on record since 1985: 24 appointments and 18 cessations. The latest: Chhayaben Ashwinbhai Shah ceased to be Director on 21 Aug 2025.

Filing
Gujarat Terce Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
AGM
Gujarat Terce Laboratories Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Ceased
Chhayaben Ashwinbhai Shah ceased to be Director.
Appointed
Avani Vishnubhai Patel was appointed as Director.
Ceased
Navinchandra Patel ceased to be Director.
Charges
A charge with Others of Rs. 8.79 Cr registered on 08 Jul 2006 with Charge ID 10011413 was modified on 20 Jun 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100504013 was registered on 20 Nov 2021.
Ceased
Jayantibhai Shankarlal Prajapati ceased to be Director.
Appointed
Navinchandra Patel was appointed as Director.
Ceased
Gordhanbhai Gandabhai Patel ceased to be Director.
Charges
A charge registered on 30 May 1995 via Charge ID 90107225 with Bank Of Baroda was fully satisfied on 03 Nov 2018.
Charges
A charge registered on 05 Jan 1995 via Charge ID 80035100 with Bank Of Baroda was fully satisfied on 03 Nov 2018.

50 earlier events are in the company report.

News

Frequently asked questions

Gujarat Terce Laboratories is an active public limited company based in Gandhinagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 March 1985 (41+ years old) and is registered under CIN L24100GJ1985PLC007753. Listed on BSE: 524314.

Gujarat Terce Laboratories reported revenue of ₹47.47 Cr for FY 2025-26 (down 5.4% YoY) based on standalone financials.

Gujarat Terce Laboratories has 6 current directors:

The latest financial statements of Gujarat Terce Laboratories on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Gujarat Terce Laboratories is 24AAACG5528L1ZK, registered in Gujarat. The company has 9 GST registrations in all, of which 7 are active and 2 are cancelled or inactive. Other active GSTINs include 24AAACG5528L2ZJ (Gujarat), 08AAACG5528L1ZE (Rajasthan), 09AAACG5528L1ZC (Uttar Pradesh).

The CIN (Corporate Identification Number) of Gujarat Terce Laboratories is L24100GJ1985PLC007753. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Gujarat Terce Laboratories is a listed company as per MCA records. Its shares are listed on BSE (code: 524314).

Gujarat Terce Laboratories has 36 court cases on record: 28 filed by the company and 8 filed against it. 16 are pending. Most are in the high courts.

Gujarat Terce Laboratories was incorporated on 28 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Gujarat Terce Laboratories has 54 deals on record (54 market trades); the latest was in June 2025.

The peers of Gujarat Terce Laboratories by revenue are D.J.Laboratories Private Limited, Magbro Health Care Private Limited, Ion Healthcare Private Limited, Pioneer Agro Industries Sanvin Laboratories Private Limited, Ultratech India Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Chhayaben Ashwinbhai Shah ceased to be Director on 21 Aug 2025. Avani Vishnubhai Patel was appointed as Director on 26 May 2025. Navinchandra Patel ceased to be Director on 19 May 2025. Gujarat Terce Laboratories has 42 board changes on record in total.